Literature DB >> 28861347

Association of the macrophage migration inhibitory factor promoter polymorphisms with benign lymphoepithelial lesion of lacrimal gland.

Qin-Jian Li1, Peng-Xiang Zhao1, Xu-Juan Zhang1, Yang Yi1, Dan-Ying Cheng2, Jian-Min Ma3, Xue-Mei Ma1.   

Abstract

AIM: To identify the association of the macrophage migration inhibitory factor (MIF) gene polymorphism with the susceptibility of benign lymphoepithelial lesions (BLEL) of the lacrimal gland.
METHODS: A total of 40 BLEL of lacrimal gland cases were matched with 40 healthy subjects (HS). Extraction the plasma and whole blood DNA of patients of lacrimal gland BLEL and HS. Elisa and polymerase chain reaction was used to determine in plasma contents of MIF and MIF gene SNP-173G>C and STR -794 CATT(5-8) polymorphism, respectively.
RESULTS: The MIF levels in plasma were significantly higher in patients with lacrimal gland BLEL versus HS (P<0.001). The -173 G>C MIF polymorphism was significantly associated with lacrimal gland BLEL, with a significantly higher frequency of the C allele in lacrimal gland BLEL patients compared with HS (OR=2.38, 95% CI=1.07-5.31, P=0.032), and the -173 C/x is more frequent in patients than in HS, P=0.037. Besides, we found that the carriage rate of the MIF -173C/x is associated with higher plasma levels of MIF in the BLEL of lacrimal gland.
CONCLUSION: MIF -173G/C variants play an insidious role in susceptibility of BLEL of lacrimal gland. Otherwise, there is no statistically significant correlation exists between MIF-794 CATT (5-8) and BLEL of lacrimal gland.

Entities:  

Keywords:  benign lymphoepithelial lesion; gene polymorphism; lacrimal gland; macrophage migration inhibitory factor

Year:  2017        PMID: 28861347      PMCID: PMC5554840          DOI: 10.18240/ijo.2017.08.07

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  24 in total

1.  Macrophage migration inhibitory factor (MIF) -173 polymorphism is associated with clinical erythema nodosum in Löfgren's syndrome.

Authors:  B Karakaya; C H M van Moorsel; A H M van der Helm-van Mil; T W J Huizinga; H J T Ruven; J J van der Vis; J C Grutters
Journal:  Cytokine       Date:  2014-06-17       Impact factor: 3.861

2.  Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids.

Authors:  L Santos; P Hall; C Metz; R Bucala; E F Morand
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

3.  The so-called 'benign lymphoepithelial lesion'. Part II. Clinical and pathological considerations with regard to evolution.

Authors:  A Ferlito; N Cattai
Journal:  J Laryngol Otol       Date:  1980-11       Impact factor: 1.469

4.  Mechanism of a reaction in vitro associated with delayed-type hypersensitivity.

Authors:  B R Bloom; B Bennett
Journal:  Science       Date:  1966-07-01       Impact factor: 47.728

5.  Macrophage migration inhibitory factor (MIF) and oligoarticular juvenile idiopathic arthritis (o-JIA): association of MIF promoter polymorphisms with response to intra-articular glucocorticoids.

Authors:  M Vivarelli; L E D'Urbano; A Insalaco; M Lunt; F Jury; A E Tozzi; A Ravelli; A Martini; R Donn; F De Benedetti
Journal:  Clin Exp Rheumatol       Date:  2007 Sep-Oct       Impact factor: 4.473

6.  Association study between macrophage migration inhibitory factor-173 polymorphism and acute myeloid leukemia in Taiwan.

Authors:  Latha Ramireddy; Chien-Yu Lin; Su-Ching Liu; Wan-Yu Lo; Rouh-Mei Hu; Yi-Chin Peng; Ching-Tien Peng
Journal:  Cell Biochem Biophys       Date:  2014-11       Impact factor: 2.194

7.  Association of the -173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis.

Authors:  Hiroaki Nohara; Naoko Okayama; Nagamu Inoue; Yuji Koike; Kozue Fujimura; Yutaka Suehiro; Yuichiro Hamanaka; Singo Higaki; Hideo Yanai; Tomoharu Yoshida; Toshifumi Hibi; Kiwamu Okita; Yuji Hinoda
Journal:  J Gastroenterol       Date:  2004       Impact factor: 7.527

8.  MIF as a glucocorticoid-induced modulator of cytokine production.

Authors:  T Calandra; J Bernhagen; C N Metz; L A Spiegel; M Bacher; T Donnelly; A Cerami; R Bucala
Journal:  Nature       Date:  1995-09-07       Impact factor: 49.962

Review 9.  IgG4-related sclerosing disease, an emerging entity: a review of a multi-system disease.

Authors:  Mukul Divatia; Sun A Kim; Jae Y Ro
Journal:  Yonsei Med J       Date:  2012-01       Impact factor: 2.759

10.  A genetic role for macrophage migration inhibitory factor (MIF) in adult-onset Still's disease.

Authors:  Fang-Fang Wang; Xin-Fang Huang; Nan Shen; Lin Leng; Richard Bucala; Shun-Le Chen; Liang-Jing Lu
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

View more
  1 in total

1.  Association of MIF gene polymorphisms with pemphigus vulgaris: a case-control study with comprehensive review of the literature.

Authors:  Parikshaa Gupta; Neha Joshi; Shradha Uprety; Sunil Dogra; Dipankar De; Sanjeev Handa; Ranjana Walker Minz; Sukhvinder Singh; Seema Chhabra
Journal:  Int J Clin Exp Pathol       Date:  2021-11-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.